Sanofi SA Company Profile (EPA:SAN)

Analyst Ratings

Consensus Ratings for Sanofi SA (EPA:SAN) (?)
Ratings Breakdown: 2 Sell Rating(s), 9 Hold Rating(s), 6 Buy Rating(s)
Consensus Rating:Hold (Score: 2.24)
Consensus Price Target: €87.71

Analysts' Ratings History for Sanofi SA (EPA:SAN)
Show:
DateFirmActionRatingPrice TargetActions
7/14/2016Jefferies GroupSet Price TargetNeutral€78.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/7/2016Kepler Capital MarketsSet Price TargetBuy€91.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/30/2016Independent Research GmbHSet Price TargetNeutral€77.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/9/2016Baader BankSet Price TargetNeutral€78.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/12/2016Barclays PLCSet Price TargetBuy€84.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/3/2016HSBCSet Price TargetNeutral€81.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/25/2016Morgan StanleySet Price TargetNeutral€90.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/6/2016Societe GeneraleSet Price TargetBuy€104.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/31/2016JPMorgan Chase & Co.Set Price TargetSell€77.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/14/2016Goldman Sachs Group Inc.Set Price TargetNeutral€80.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/18/2016Berenberg BankSet Price TargetNeutral€93.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/9/2016S&P Equity ResearchSet Price TargetBuy€85.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/10/2015BNP ParibasSet Price TargetSell€80.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/30/2015Deutsche Bank AGSet Price TargetBuy€103.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/9/2015Sanford C. BernsteinSet Price TargetNeutral€91.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/30/2015Credit Suisse Group AGSet Price TargetBuy€100.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/29/2015Citigroup Inc.Set Price TargetNeutral€99.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 7/25/2014 forward)

Earnings

Earnings History for Sanofi SA (EPA:SAN)
No earnings announcements for this company have been tracked by MarketBeat.com

Estimates

Earnings Estimates for Sanofi SA (EPA:SAN)
No earnings estimates for this company have been tracked by MarketBeat.com

Dividends

Dividend History for Sanofi SA (EPA:SAN)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Sanofi SA (EPA:SAN)
No insider trades for this company have been tracked by MarketBeat.com

Headlines

Latest Headlines for Sanofi SA (EPA:SAN)
DateHeadline
07/25/16 10:42 AMLegal updates: SC to hear Delhi govt’s appeal on CAG audit of discoms
07/25/16 08:30 AMZacks Industry Outlook Highlights: Bristol-Myers, Pfizer, Sanofi, Amgen and Biogen -
07/23/16 10:04 AMInjectable Drug Delivery Market Trends and Competitive Landscape Outlook to 2025
07/23/16 10:04 AMBiocon to launch two insulin variants in Malaysia in fiscal 2017
07/22/16 09:12 AMSanofi SA (ADR) Draws Bullish Attention After Its Gap Up Today - Consumer Eagle
07/22/16 09:12 AMHC Stocks Highlights: Amgen, Inc. (NASDAQ:AMGN), Sanofi SA (ADR) (NYSE:SNY) - share market updates (press release)
07/20/16 07:10 PMEx-Morgan Stanley Broker Inks Sanofi Insider Trading Deal
07/20/16 07:10 PMZika virus vaccine Phase I clinical trial on humans set to begin in Quebec City
07/20/16 09:08 AMWhat's Next for Sanofi SA (ADR) After Today's Gap Down? - Consumer Eagle
07/19/16 07:23 AMAttention Seekers of Healthcare: AstraZeneca plc (ADR) (NYSE:AZN), Sanofi SA (ADR) (NYSE:SNY) - Post Registrar
07/18/16 11:49 AMHC Stocks Highlights: Sanofi SA (ADR) (NYSE:SNY) Amgen, Inc. (NASDAQ:AMGN) - share market updates (press release)
07/15/16 11:29 AMMeningitis Pipeline Landscape and Therapeutics Market 2016 Review Research
07/14/16 06:30 PMWere Analysts Bearish Sanofi SA (ADR) (NYSE:SNY) This Week? - Consumer Eagle
07/14/16 06:30 PMHC Stocks Momentum: Amgen, Inc. (NASDAQ:AMGN), Sanofi SA (ADR) (NYSE:SNY) - share market updates (press release)
07/13/16 06:39 PMGlobal Pertussis (Whooping Cough) Pipeline Market 2016 Review Research
07/09/16 09:20 AMIn first, scientists use phones to track dengue outbreaks in poor nations
07/08/16 09:09 AMHC Stocks Judgment: Immunomedics, Inc. (NASDAQ:IMMU), Sanofi SA (ADR) (NYSE:SNY) - share market updates (press release)
07/08/16 09:09 AMSanofi SA (ADR) (SNY) Working With U.S. Army to Combat Zika Virus - Investorplace.com
07/08/16 08:45 AMDrugmaker Boehringer offers EU concessions for Sanofi asset swap -
07/08/16 06:07 AMPreliminary Q2 2016 Sanofi SA Earnings Release - Before Market Open -
07/07/16 06:21 PMSanofi : Navy awards $750,000 grant to Wash U. scientists to create bomb-sniffing locusts
07/07/16 06:21 PMUS Army And France's Sanofi Combine Work on Zika Vaccine
07/07/16 06:21 PMUS cancer drug company Medivation finally allows Sanofi to conduct due diligence
07/07/16 04:07 PMSanofi Pasteur (SNY) Partners With Walter Reed Army Institute to Create Zika Vaccine -
07/07/16 01:36 PMMedivation Overplays a Risky Hand -
07/07/16 09:48 AMThis $10 billion drugmaker is the hottest thing in the industry — and it knows it -
07/07/16 09:01 AMMedivation officially rejects latest Sanofi offer, may field more bids - MarketWatch
07/07/16 09:01 AMIs Selling Stock Like Sanofi SA (ADR) After Such Gap Down a Winning Strategy? - Engelwood Daily
07/07/16 09:01 AMHC Stocks Judgment: Amgen, Inc. (NASDAQ:AMGN), Sanofi SA (ADR) (NYSE:SNY) - share market updates (press release)
07/07/16 09:01 AMUS Army partners with French pharma giant to speed up Zika vaccine - CBS News
07/07/16 09:01 AMSanofi SA (ADR) (SNY) Confirmed Confidentiality Agreement with Medivation Inc (MDVN) - TCC
07/06/16 06:36 PMU.S. Army and France's Sanofi combine work on Zika vaccine
07/06/16 05:45 PMMedivation Tries to Show Why It's Worth More Than Bidders Have Offered -
07/06/16 10:53 AMUS Army Partners With Sanofi To Develop Zika Vaccine
07/06/16 10:53 AMUS Army And France's Sanofi Combine Work On Zika Virus
07/06/16 10:53 AMMedivation rejects latest Sanofi bid
07/06/16 10:53 AMSanofi SA (SNY) Down Amid Medivation Talks
07/05/16 05:57 PMExclusive: Medivation discusses potential sale to Sanofi - sources - Channel NewsAsia
07/05/16 05:57 PMRegeneron Pharmaceuticals Inc (NASDAQ:REGN), Sanofi SA (NYSE:SNY) Clinch Marketing Authorization for Praluent ... - Market Exclusive
07/05/16 05:54 PMSanofi, Pfizer, Celgene may each pursue Medivation takeover -
07/04/16 10:52 AMSanofi seeks CCI nod for asset swap deal with BI; stock trading higher
07/02/16 08:54 AMZika-damaged babies could appear normal, says study
07/02/16 08:54 AMThird Zika case reported in Duval County
07/01/16 06:15 PMSanofi SA (ADR) Rises A lot Today, Is Now One of The Best Performer - Engelwood Daily
07/01/16 09:02 AMHC Stocks Buzzer: Baxter International Inc (NYSE:BAX), Sanofi SA (ADR) (NYSE:SNY) - share market updates (press release)
06/30/16 09:02 AMNotable Stocks to Watch: Sanofi SA (NYSE:SNY), LyondellBasell Industries NV (NYSE:LYB) - NYSE Journal (press release)
06/30/16 09:02 AMHC Stocks Reports Analysis: Sanofi SA (ADR) (NYSE:SNY), XOMA Corp (NASDAQ:XOMA) - share market updates (press release)
06/29/16 06:08 PMCAC 40 Tumbles Lower as Hollande Visits Germany to Discuss the U.K.
06/28/16 11:03 AMGlobal Anti-Adhesion Products Market 2015-2022 - Clinicians and Healthcare Systems: Major Growth Determinants
06/28/16 11:03 AMSanofi Investors Lose Bid To Revive Kickback Allegations

Social

About Sanofi SA

Sanofi SA logoSanofi SA is a healthcare company focused on patient needs and engaged in the research, development, manufacture and marketing of healthcare products. The Company is organized around three principal activities: Pharmaceuticals, Human Vaccines via Sanofi Pasteur, and Animal Health via Merial. The Company invests in emerging markets, diabetes solutions, vaccines, consumer health care, animal health, genzyme and other products. The emerging markets platform includes products from all three of the Company's principal activities. Under the Company's Pharmaceuticals business, products are grouped into the key fields of diabetes solutions, rare diseases, multiple sclerosis, oncology, thrombosis and cardiovascular disease prevention, nephrology and bio-surgery. The Human Vaccines activity is operated through Sanofi Pasteur. The Animal Health activity is carried out through Merial.

Industry, Sector and Symbol:
  • Sector: N/A
  • Industry: N/A
  • Sub-Industry: N/A
  • Exchange: EPA
  • Symbol: SAN
  • CUSIP:
Key Metrics:
  • Previous Close: $76.60
  • 50 Day Moving Average: $25.64
  • 200 Day Moving Average: $25.49
  • P/E Ratio: 23.11
  • P/E Growth: 0.00
  • Market Cap: $98.61B
  • Current Year EPS Consensus Estimate: $ EPS
  • Next Year EPS Consensus Estimate: $ EPS
Additional Links: